-
Body Mass Index at 11-13 Weeks' Gestation and Pregnancy Complications.
Syngelaki A, Bredaki FE, Vaikousi E, Maiz N, Nicolaides KH.
Fetal Diagn Ther 2011;30:250-65. -
Placental volume at 11-13 weeks' gestation in the prediction of birth weight percentile.
Plasencia W, Akolekar R, Dagklis T, Veduta A, Nicolaides KH.
Fetal Diagn Ther 2011;30:23-8. -
Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects.
Pereira S, Ganapathy R, Syngelaki A, Maiz N, Nicolaides KH.
Obstet Gynecol 2011;117:1384-91. -
Ductus venosus flow at 11-13 weeks in the prediction of birth weight discordance in monochorionic twins.
Matias A, Maiz N, Montenegro N, Nicolaides K.
J Perinat Med 2011;39:467-70. -
Contribution of ductus venosus doppler in first-trimester screening for major cardiac defects.
Chelemen T, Syngelaki A, Maiz N, Allan L, Nicolaides KH.
Fetal Diagn Ther 2011;29:127-34. -
Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications.
Maiz N, Nicolaides KH.
Fetal Diagn Ther 2010;28:65-71. -
Customized birth weight: coefficients and validation of models in a UK population.
Sahota DS, Kagan KO, Lau TK, Leung TY, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:884-9. -
Intrauterine growth in multiple pregnancies in relation to fetal number, chorionicity and gestational age.
Papageorghiou AT, Bakoulas V, Sebire NJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:890-3. -
Two and three-dimensional imaging of coarctation shelf in the human fetus.
Molina FS, Nicolaides KH, Carvalho JS.
Heart 2008;94:584. -
Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K.
Ultrasound Obstet Gynecol 2008;31:256-60. -
Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH.
Obstet Gynecol 2008;112:598-605. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Nuchal translucency and the risk of congenital heart disease.
Hyett J, Sonek J, Nicolaides KH.
Obstet Gynecol 2007;109:1455-6. -
Relation between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.
Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH.
Ultrasound Obstet Gynecol 2005;26:154-7. -
Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
Ghi T, Huggon IC, Zosmer N, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:610-4. -
Nuchal translucency as a marker of congenital heart disease.
Perdu M, Hyett JA, Sharland G, Snijders RS, Nicolaides KH.
Contracept Fertil Sex 1999;27:I-V. -
Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:307-10. -
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH.
BMJ 1999;318:81-5. -
Intertwin disparity in fetal size in monochorionic and dichorionic pregnancies.
Sebire NJ, D'Ercole C, Soares W, Nayar R, Nicolaides KH.
Obstet Gynecol 1998;91:82-5. -
Cardiac expression of sarcoplasmic reticulum calcium ATPase in fetuses with trisomy 21 and trisomy 18 presenting with nuchal translucency.
von Kaisenberg CS, Huggon I, Hyett JA, Farzaneh F, Nicolaides KH.
Fetal Diagn Ther 1997:12:270-3.